Literature DB >> 22981405

The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis.

Cheng-Jui Lin1, Chi-Feng Pan, Hsuan-Liang Liu, Chih-Kuang Chuang, Thanasekaran Jayakumar, Tuen-Jen Wang, Han-Hsiang Chen, Chih-Jen Wu.   

Abstract

OBJECTIVE: p-Cresyl sulfate (PCS) and indoxyl sulfate (IS) have been reported to predict poor clinical outcomes in hemodialysis (HD) patients. However, little is known about the effect of the two toxins on peripheral arterial disease (PAD) and vascular access dysfunction. Our objective was to explore the association between the two toxins and PAD and vascular access failure (VAF) in a hemodialysis-based cohort.
METHODS: We enrolled 100 stable and eligible HD patients from a single medical center. These patients were screened for PAD by machine and recorded as ABI (ankle brachial index) and brachial-ankle PWV (pulse wave velocity). Serum levels of PCS, IS and biochemical data were also collected concurrently. In addition, we also recorded the first event of VAF and frequency of PTA and thrombectomy during 3-year follow-up.
RESULTS: Total and free PCS were correlated to right and left ABI and PWV (p < 0.01), and total IS was associated with right and left ABI (p < 0.01) by Pearson's analysis. Repeated measuring by mixed model analysis revealed that serum albumin (p = 0.003), cholesterol (p = 0.01) and total PCS (p = 0.031) had significant correlation with ABI after adjusting other confounding factors. As for brachial-ankle PWV, serum triglyceride (p = 0.002), total IS (p = 0.04) and total PCS (p = 0.050) reached significance finally. In addition, multivariate Cox regression analysis revealed dialysis length and total PCS were related to AV-shunt failure event (Hazard Ratio: 1.14, p = 0.01, and Hazard Ratio: 1.04, p = 0.04, respectively). Both of total and free PCS and IS were also positively linked to numbers of PTA and thrombectomy. Further, the Kaplan-Meier analysis showed only total PCS was significantly associated with vascular access failure event (log rank P = 0.02).
CONCLUSION: This study shows that the serum levels of PCS and IS were associated with PAD and total PCS could be a valuable determinant of access viability other than traditional or nontraditional risk factors in HD patients.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22981405     DOI: 10.1016/j.atherosclerosis.2012.07.012

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  28 in total

1.  DNA hypermethylation of sFRP5 contributes to indoxyl sulfate-induced renal fibrosis.

Authors:  Yanlin Yu; Xu Guan; Ling Nie; Yong Liu; Ting He; Jiachuan Xiong; Xinli Xu; Yan Li; Ke Yang; Yiqin Wang; Yunjian Huang; Bing Feng; Jingbo Zhang; Jinghong Zhao
Journal:  J Mol Med (Berl)       Date:  2017-05-15       Impact factor: 4.599

Review 2.  Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies.

Authors:  Wei Pan; Yongbo Kang
Journal:  Int Urol Nephrol       Date:  2017-08-28       Impact factor: 2.370

3.  Sclerostin as a new key player in arteriovenous fistula calcification.

Authors:  M Balcı; A Kırkpantur; A Turkvatan; S Mandıroglu; E Ozturk; B Afsar
Journal:  Herz       Date:  2013-10-19       Impact factor: 1.443

4.  Human organic anion transporters function as a high-capacity transporter for p-cresyl sulfate, a uremic toxin.

Authors:  Hiroshi Watanabe; Yoshiaki Sakaguchi; Ryusei Sugimoto; Ken-Ichi Kaneko; Hiroshi Iwata; Shunsuke Kotani; Makoto Nakajima; Yu Ishima; Masaki Otagiri; Toru Maruyama
Journal:  Clin Exp Nephrol       Date:  2013-11-02       Impact factor: 2.801

5.  The Arrhythmogenic Effect of Protein-Bound Uremic Toxin p-Cresylsulfate: An In Vitro Study.

Authors:  I-Ting Tsai; Chia-Chang Hsu; Wei-Chin Hung; Chao-Ping Wang; Teng-Hung Yu; Jer-Yiing Houng; Kun-Tai Lee; Wei-Hua Tang
Journal:  Acta Cardiol Sin       Date:  2019-11       Impact factor: 2.672

Review 6.  Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?

Authors:  Carolla El Chamieh; Sophie Liabeuf; Ziad Massy
Journal:  Toxins (Basel)       Date:  2022-04-14       Impact factor: 5.075

Review 7.  Cellular and Molecular Mechanisms of Chronic Kidney Disease with Diabetes Mellitus and Cardiovascular Diseases as Its Comorbidities.

Authors:  Prathibha Reddy Gajjala; Maryam Sanati; Joachim Jankowski
Journal:  Front Immunol       Date:  2015-07-08       Impact factor: 7.561

8.  Moderate Increase of Indoxyl Sulfate Promotes Monocyte Transition into Profibrotic Macrophages.

Authors:  Chiara Barisione; Silvano Garibaldi; Anna Lisa Furfaro; Mariapaola Nitti; Daniela Palmieri; Mario Passalacqua; Anna Garuti; Daniela Verzola; Alessia Parodi; Pietro Ameri; Paola Altieri; Patrizia Fabbi; Pier Francesco Ferrar; Claudio Brunelli; Violeta Arsenescu; Manrico Balbi; Domenico Palombo; Giorgio Ghigliotti
Journal:  PLoS One       Date:  2016-02-29       Impact factor: 3.240

Review 9.  The aryl hydrocarbon receptor-activating effect of uremic toxins from tryptophan metabolism: a new concept to understand cardiovascular complications of chronic kidney disease.

Authors:  Marion Sallée; Laetitia Dou; Claire Cerini; Stéphane Poitevin; Philippe Brunet; Stéphane Burtey
Journal:  Toxins (Basel)       Date:  2014-03-04       Impact factor: 4.546

10.  P-cresyl sulfate is a valuable predictor of clinical outcomes in pre-ESRD patients.

Authors:  Cheng-Jui Lin; Chi-Feng Pan; Chih-Kuang Chuang; Fang-Ju Sun; Duen-Jen Wang; Han-Hsiang Chen; Hsuan-Liang Liu; Chih-Jen Wu
Journal:  Biomed Res Int       Date:  2014-01-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.